Micropaque

Barium sulfate, the active ingredient in Micropaque, is a contrast media presented as an oral suspension for oral use. It provides radiopaque contrast for imaging of the gastrointestinal tract in patients undergoing diagnostic radiology procedures, helping to visualize the esophagus, stomach, duodenum and colon.

GNH USA supplies Micropaque as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Micropaque is a barium‑based contrast agent used for gastrointestinal radiographic examinations.

- Barium swallow: visualizes the esophagus and detects structural abnormalities. - Barium meal: outlines the stomach and duodenum for assessment of mucosal lesions. - Barium enema: delineates the colon to identify polyps, strictures or inflammatory changes. - Upper GI series: provides comprehensive imaging of the esophagus, stomach and duodenum in a single study.

Micropaque may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate discomfort after ingestion. - Abdominal cramping: intermittent pain during bowel movement of barium. - Vomiting: occasional expulsion of the suspension. - Diarrhea: loose stools as the barium passes through. - Constipation: delayed transit leading to hard stools. - Transient taste alteration: metallic or chalky aftertaste.

Serious or Rare Side Effects: - Aspiration pneumonitis: inhalation of barium causing lung inflammation. - Severe allergic reaction (anaphylaxis): rare but requires immediate medical attention. - Barium impaction: blockage of the bowel, especially in patients with strictures. - Perforation risk: if a pre‑existing gastrointestinal lesion is present, barium may exacerbate injury. - Electrolyte imbalance: rare, due to extensive fluid shifts. - Persistent abdominal pain: may indicate obstruction or irritation.

Prior to using Micropaque, several safety considerations should be observed.

- Assess for gastrointestinal obstruction: avoid use in patients with known strictures or perforations. - Check for hypersensitivity: discontinue if allergic reaction occurs. - Ensure adequate hydration: promote clearance of barium from the GI tract. - Avoid use in recent bowel surgery patients unless cleared by a surgeon. - Pregnancy and lactation: use only if clearly needed, as safety has not been established. - Store at ambient temperature: keep below 25°C, retain original packaging, and protect from moisture.

Micropaque can interact with other agents that affect gastrointestinal function or imaging interpretation.

Major Interactions (Avoid): - Concurrent oral iodine‑based contrast agents: may interfere with radiographic assessment. - Medications that reduce GI motility (e.g., anticholinergics, opioids): increase risk of barium retention.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may alter suspension consistency. - Chelating agents: could affect barium dispersion. - Radiopharmaceuticals: timing should be coordinated to avoid overlapping imaging studies.